India’s drug trust crisis is widening as Sun Pharma, Torrent, and Alkem come under scrutiny for alleged “not of standard quality” medicines. Government agencies recently pulled up more than 50 popular brands, raising fears that the supply chain may be allowing inferior drugs to slip through. The big question now is how patients can reliably trust what they take.
After 70 children died in Gambia in 2022 linked to contaminated cough syrups, India’s pharma sector and its top regulator faced a credibility crisis. Rajeev Raghuvanshi, appointed Drug Controller General of India, is now pushing a transformation aimed at closing regulatory gaps and tightening product quality. The big question: can enforcement finally keep pace?
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
A Gujarat-based NGO is urging the government to regulate nutraceuticals such as health supplements under drug regulators, not food safety authorities. The group alleges uneven product quality and unregulated pricing, arguing the current framework leaves consumers exposed. If accepted, the proposal could bring tighter standards and more transparent costs for nutraceuticals nationwide.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
